{
    "applicationNumber": "BR 11 2023 000423-3",
    "filingDate": "09/07/2021",
    "grantDate": null,
    "title": "COMBINA\u00c7\u00d5ES DE AGONISTAS GABAA ALFA 5 E INIBIDORES DE SV2A E M\u00c9TODOS DE USO NO TRATAMENTO DE COMPROMETIMENTO COGNITIVO",
    "nationalPhaseDate": [
        "09/01/2023"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/041184",
        "pctDate": "09/07/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/050,730",
            "priorityDate": "10/07/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2715"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2723"
        }
    ],
    "inventors": [
        "MICHELA GALLAGHER",
        "SHARON ROSENZWEIG"
    ],
    "holders": [
        114738
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 31/4015",
        "A61P 25/28",
        "C07D 519/00",
        "C07D 487/14",
        "A61K 31/5517"
    ]
}